Sign In
Buy AMRS
$0.0500
+0 (+0%)
At Close: Nov 27, 2023
Synthetic Biology Market 2020-2024 | Investment in Synthetic Biology Process and Techniques to Boost Growth | Technavio
12:00am, Monday, 01'st Jun 2020
The Global Synthetic Biology Market will grow by $ 11.52 bn during 2020-2024
Top Marijuana Stocks for June 2020
05:56pm, Friday, 29'th May 2020
The marijuana industry is made up of companies that either support or are engaged in the research, development, distribution, and sale of medical and recreational marijuana. Many companies in the you
Top Marijuana Stocks on the NASDAQ for June 2020
03:38pm, Thursday, 28'th May 2020
These are the NASDAQ-listed marijuana stocks with the best value, fastest growth, and most momentum for June.
Penny Stocks to Watch for June 2020
05:33pm, Wednesday, 27'th May 2020
While markets appear to be poised for a downtick, these low-priced stocks could see gains over the coming weeks.
Amyris Launches Safe Alternative To Talc-Based Baby Powder
01:18pm, Thursday, 21'st May 2020
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today a
Amyris Reports Launch Of Safe Alternative To Talc-Based Baby Powder
12:00am, Thursday, 21'st May 2020Is Another Accounting Issue Brewing for Amyris?
12:00am, Monday, 18'th May 2020
Investors are less than two years removed from a significant accounting discrepancy. A closer look at SEC filings reveals another potential cause for concern.
Amyris Changes its 2020 Annual Meeting of Stockholders to Virtual Format
12:30pm, Friday, 15'th May 2020
Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biotechnology company with leadership in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingre
Is Amyris Finally Turning a Corner?
01:36pm, Thursday, 14'th May 2020
Investors were pleased by relatively positive operating results in the first quarter of 2020. Can the synthetic biology company turn those results into a durable trend?
Amyris Receives GRAS Validation by Medical Expert Panel for its New Health and Nutrition Ingredient
12:30pm, Thursday, 14'th May 2020
Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biotechnology company with leadership in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingre
Amyris: The Future, Accelerated
06:20pm, Tuesday, 12'th May 2020
The Coronavirus is accelerating the future. Amyris moves with incredible speed to launch a hit product. Latest quarterly results deliver on the promise of 60% g
BRIEF-Amyris Inc Says Files For Offer And Sale Of Up To 35.51 Mln Shares Of Common Stock by The Selling Stockholders
02:16pm, Tuesday, 12'th May 2020
* AMYRIS INC SAYS FILES FOR OFFER AND SALE OF UP TO 35.51 MILLION SHARES OF COMMON STOCKBY THE SELLING STOCKHOLDERS - SEC FILING Source text : (https://bit.ly/2LooEbS) Further company coverage:
6 Stock Charts To Watch: AMRS, CYTK, DRNA, LX, MRNA, VAPO
12:00am, Tuesday, 12'th May 2020
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Amyris Inc, BioCryst Pharmaceuticals Inc, Cytokinetics Inc. Read Harry Boxer's latest article on Investing.com
Amyris, Inc. (AMRS) CEO John Melo on Q1 2020 Results - Earnings Call Transcript
10:04pm, Friday, 08'th May 2020
Amyris, Inc. (NASDAQ:AMRS) Q1 2020 Earnings Conference Call May 8, 2020 09:00 ET Company Participants Peter DeNardo - Senior Director-Investor Relations and Cor
